MOLECULAR MECHANISMS OF ORGANOPHOSPHATE IMMUNOTOXICITY
MOLECULAR MECHANISMS OF ORGANOPHOSPHATE IMMUNOTOXICITY
批准号:
3465160
负责人:
KATHLEEN E. RODGERS
金额:
$8.38万
依托单位国家:
美国
项目类别:
财政年份:
1986
资助国家:
美国
项目状态:
已结题
起止时间:
1986-09-01 至 1993-06-30
关键词:
autoradiography cell differentiation cell type cellular immunity chemical structure function chemical synthesis colorimetry covalent bond diagnosis design /evaluation environmental toxicology enzyme inhibitors enzyme mechanism flow cytometry free radicals gel electrophoresis human tissue immunoprecipitation immunosuppression immunotoxicity insecticide biological effect iodine laboratory mouse leukocyte activation /transformation macrophage molecular site organophosphorus insecticide parathion pesticide interaction radionuclides radiotracer rapid diagnosis scintillation counter superoxides tissue /cell culture toxicant screening
中文摘要
免疫抑制的分子机制,由两个杂质中,
有机磷农药马拉硫磷、乙酰甲胺磷和杀螟松,
O,O,S-三甲基硫代磷酸酯(OOS-TMP)和O,S,S-三甲基
二硫代磷酸酯,将被检查。 巨噬细胞,通过细胞
分离和重组实验,已被证明是
受OOS-TMP处理影响最大的淋巴样细胞。 中的阻塞
巨噬细胞的成熟,这发生在急性施用
将确定OOS-TMP。 研究将包括巨噬细胞
细胞表面标志物Ia、Mac-1、Mac-2和F4/80,功能活性和
分泌产物 结构类似物OSS-TMP的抑制作用
对细胞溶解效应器功能的影响将使用
功能上确定的细胞毒性T淋巴细胞(CTL)和其他细胞溶解性T淋巴细胞(CTL),
效应细胞 阻断鼠CTL功能的位点将是
使用缀合物形成和Ca 2+脉冲技术测定。 的
将使用放射性标记的OSS-TMP鉴定分子位点,
生化分析 此外,还改进了比色测定法,
(dye将研究其适用性
作为细胞毒性和细胞抑制活性的筛选试验,
环境毒物 该测定可作为标准品的替代品
台盼蓝排除法用于评估细胞活力。
英文摘要
The molecular mechanisms of immune suppression by two impurities in the
organosphosphate pesticides, malathion, acephate and fenitrothion,
O,O,S-trimethyl phosphorothioate (OOS-TMP) and O,S,S-trimethyl
phosphorodithioate, will be examined. Macrophaages, through cell
separation and reconstitution experiments, have been shown to be the
lymphoid cell most affected by OOS-TMP treatment. The blockage in the
maturation of macrophages which occurs following acute administration of
OOS-TMP will be identified. Studies will include changes in macrophage
cell surface markers, Ia, Mac-1, Mac-2 and F4/80, functional activity and
secretory products. The inhibitory effect of a structural analog OSS-TMP
on cytolytic effector function will be examined in detail using
functionally defined cytotoxic T lymphocytes (CTL) and other cytolytic
effector cells. The site(s) of the blockade of murine CTL function will be
determined using conjugate formation and Ca2+ pulse techniques. The
molecular sites will be identified using radiolabelled OSS-TMP and
biochemical analyses. In addition, an adaptation of a colorimetric assay
(dye reduction) for cell viability will be investigated for its suitability
as a screening assay for the cytotoxic and cytostatic activities of
environmental toxicants. This assay may be an alternative to the standard
trypan blue exclusion method for assessing cell viability.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
-
批准号:10530821
-
项目类别:
-
资助金额:$38.38万
-
财政年份:2020
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
-
批准号:10396541
-
项目类别:
-
资助金额:$151.56万
-
财政年份:2020
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
IND Enabling Studies for RASRx 1902, a novel Mas receptor agonist, for treatment of cognitive impairment in patients at risk for Alzheimer's disease.
-
批准号:10644987
-
项目类别:
-
资助金额:$152.86万
-
财政年份:2020
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
A(1-7)-Mediated Mitigation of Radiation Induced Thrombocytopenia
-
批准号:8058309
-
项目类别:
-
资助金额:$43.16万
-
财政年份:2010
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
NorLeu3-A(1-7): Enhanced Recovery of Radiation Burns
-
批准号:8055215
-
项目类别:
-
资助金额:$67.43万
-
财政年份:2010
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin(1-7): A Target in Diabetic Cardiac Ischemia
-
批准号:7609180
-
项目类别:
-
资助金额:$34.15万
-
财政年份:2008
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin(1-7): A Target in Diabetic Cardiac Ischemia
-
批准号:7797462
-
项目类别:
-
资助金额:$34.05万
-
财政年份:2008
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
A(1-7)-Mediated Mitigation of Radiation Induced Thrombocytopenia
-
批准号:7552457
-
项目类别:
-
资助金额:$90.74万
-
财政年份:2008
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin(1-7): A Target in Diabetic Cardiac Ischemia
-
批准号:7462238
-
项目类别:
-
资助金额:$35.72万
-
财政年份:2008
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
NorLeu3-A(1-7): Enhanced Recovery of Radiation Burns
-
批准号:7575590
-
项目类别:
-
资助金额:$94.23万
-
财政年份:2008
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:7414073
-
项目类别:
-
资助金额:$85.92万
-
财政年份:2007
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:8134084
-
项目类别:
-
资助金额:$20.73万
-
财政年份:2007
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:7270998
-
项目类别:
-
资助金额:$92.41万
-
财政年份:2007
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:7624290
-
项目类别:
-
资助金额:$86.08万
-
财政年份:2007
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Project 3: Peripheral Immune Activation on the Road to Development of Alzheimer's Disease: Therapeutic Targets and Windows
-
批准号:10172751
-
项目类别:
-
资助金额:$37.13万
-
财政年份:2006
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Project 3: Peripheral Immune Activation on the Road to Development of Alzheimer's Disease: Therapeutic Targets and Windows
-
批准号:10412244
-
项目类别:
-
资助金额:$37.05万
-
财政年份:2006
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Project 3: Peripheral Immune Activation on the Road to Development of Alzheimer's Disease: Therapeutic Targets and Windows
-
批准号:10659128
-
项目类别:
-
资助金额:$40.61万
-
财政年份:2006
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:6945913
-
项目类别:
-
资助金额:$42.97万
-
财政年份:2004
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
Angiotensin Analogs to Treat Wound Healing
-
批准号:6741664
-
项目类别:
-
资助金额:$96.03万
-
财政年份:2004
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
ANGIOTENSIN ANALOGS TO TREAT WOUND HEALING
-
批准号:6292904
-
项目类别:
-
资助金额:$10.0万
-
财政年份:2001
-
负责人:KATHLEEN E. RODGERS
-
依托单位:
海外基金